Sisters4Prevention Breast Cancer Stories and Survival
Since my diagnosis fourteen years ago, I have been dedicated to researching lifestyle changes and supporting clinical research to achieve the prevention of breast cancer. My goal is to raise awareness of the need for research funding for the primary prevention of women's cancers and to share information to help those facing this journey. My posts are educational and include my journey with bilateral breast cancer and my year of treatment including a double mastectomy and reconstruction. I have been a breast cancer advocate since 2010 and have served on panels at the department of defense breast cancer funding review programs. My website shares all the information I have collected and verified from long term survivors and medical evidence. I am not a medical professional, simply a teacher who hopes to make a difference by sharing information. I presently serve as one of three breast cancer advocates on the pending clinical trial under the direction of Dr. Vincent Tuohy at the Cleveland clinic to prevent the recurrence of triple negative breast cancer, the most lethal form of the disease began in the Fall of in 2021.I am a graduate of the National Breast Cancer Coalition's Project LEAD and have lobbied Congress for additional funds for prevention clinical trials for breast and ovarian cancers. In 2022, I was invited to be a Komen Advocate in Science. Stay tuned...
Sisters4Prevention Breast Cancer Stories and Survival
Explanation of Oncotype DX - A Game Changer for Early Stage Breast Cancer
A complete explanation of the scoring system for the oncotype DX test and it's benefits for early stage, node negative, hormone positive, Her2 negative breast cancer. The trend towards "individualized oncology" in the past ten years has changed the focus from "one size fits all" to examining the genomic characteristics of the tumor cells. Early stage breast cancers treated prior to this diagnostic test were all given chemotherapy. This test identifies tumors who would not respond to chemotherapy and allows these patients to skip this debilitating treatment and treat their cancer with hormone therapy.